138 related articles for article (PubMed ID: 38146386)
41. The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.
Gontero P; Oderda M; Mehnert A; Gurioli A; Marson F; Lucca I; Rink M; Schmid M; Kluth LA; Pappagallo G; Sogni F; Sanguedolce F; Schiavina R; Martorana G; Shariat SF; Chun F
J Urol; 2013 Sep; 190(3):857-62. PubMed ID: 23545101
[TBL] [Abstract][Full Text] [Related]
42. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
Shepherd AR; Shepherd E; Brook NR
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
[TBL] [Abstract][Full Text] [Related]
43. A case of disseminated
Nishimura M; Okumura M; Takemasa T; Yoshiyama T; Tanaka Y; Saotome M; Ohta K
Respir Med Case Rep; 2023; 45():101902. PubMed ID: 37538979
[TBL] [Abstract][Full Text] [Related]
44. [Sepsis and multiple organ failure after BCG-instillation for bladder cancer].
Elmer A; Bermes U; Drath L; Büscher E; Viertel A
Internist (Berl); 2004 Aug; 45(8):935-9. PubMed ID: 15138643
[TBL] [Abstract][Full Text] [Related]
45. Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
Vallilas C; Zachou M; Dolkiras P; Sakellariou S; Constantinou CA; Flevari P; Anastasopoulou A; Androutsakos T
Am J Case Rep; 2021 Oct; 22():e933006. PubMed ID: 34654796
[TBL] [Abstract][Full Text] [Related]
46. Healthcare-Associated Mycobacterium bovis-Bacille Calmette-Guérin (BCG) Infection in Cancer Patients Without Prior BCG Instillation.
Meije Y; Martínez-Montauti J; Caylà JA; Loureiro J; Ortega L; Clemente M; Sanz X; Ricart M; Santomà MJ; Coll P; Sierra M; Calsina M; Vaqué M; Ruiz-Camps I; López-Sánchez C; Montes M; Ayestarán A; Carratalà J; Orcau À
Clin Infect Dis; 2017 Oct; 65(7):1136-1143. PubMed ID: 28575173
[TBL] [Abstract][Full Text] [Related]
47. Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study.
Hsu CW; Chiu YC; Hu HY; Fan YH; Hong SC; Cheng WM
BMC Urol; 2020 Jul; 20(1):91. PubMed ID: 32641099
[TBL] [Abstract][Full Text] [Related]
48. Aortobisiliac graft thrombosis in bacillus Calmette-Guérin disseminated infection with graft involvement.
Ciofani L; Milani R; Giordano J; Cevolani M
J Vasc Surg Cases Innov Tech; 2024 Aug; 10(4):101504. PubMed ID: 38818509
[TBL] [Abstract][Full Text] [Related]
49. Systemic Bacillus Calmette-Guérin (BCG) Infection and Accompanying Warm Autoimmune Haemolytic Anaemia Following Intravesical BCG Immunotherapy.
Güven AT; Demiroğlu YZ; Koçer NE
Eur J Case Rep Intern Med; 2023; 10(9):004009. PubMed ID: 37680784
[TBL] [Abstract][Full Text] [Related]
50. Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin.
Izes JK; Bihrle W; Thomas CB
J Urol; 1993 Nov; 150(5 Pt 1):1498-1500. PubMed ID: 8411436
[TBL] [Abstract][Full Text] [Related]
51. Bone marrow infection with bacillus Calmette-Guérin (BCG) after intravesical immunotherapy.
Nemeth J; Stoiser B; Winkler HM; Müllauer L; Graninger W; Winkler S
Wien Klin Wochenschr; 2008; 120(3-4):121-3. PubMed ID: 18322775
[TBL] [Abstract][Full Text] [Related]
52. Disseminated Bacillus Calmette-Guerin infections after intravesical therapy.
Gerogianni I; Gravas S; Gourgoulianis K; Neonakis I; Petinaki E
Indian J Med Microbiol; 2014; 32(4):438-9. PubMed ID: 25297033
[TBL] [Abstract][Full Text] [Related]
53. Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy.
Delimpoura V; Samitas K; Vamvakaris I; Zervas E; Gaga M
BMJ Case Rep; 2013 Oct; 2013():. PubMed ID: 24114600
[TBL] [Abstract][Full Text] [Related]
54. Tuberculous spondylitis following intravesical bcg-instillation in the treatment of transitional cell carcinoma: Case report and systematic review.
Broekx S; Buelens E
Clin Neurol Neurosurg; 2020 Jul; 194():105944. PubMed ID: 32480296
[TBL] [Abstract][Full Text] [Related]
55. A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer.
Robinson ARL; Radhakrishnan R; Horvath R; Pandey S
Intern Med J; 2017 Jul; 47(7):820-823. PubMed ID: 28677313
[TBL] [Abstract][Full Text] [Related]
56. Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model.
Erdoğar N; Iskit AB; Eroğlu H; Sargon MF; Mungan NA; Bilensoy E
J Nanosci Nanotechnol; 2015 Dec; 15(12):10156-64. PubMed ID: 26682462
[TBL] [Abstract][Full Text] [Related]
57. Differences between a probable and proven BCG infection following intravesical instillations: 16 years experience in a tertiary care hospital.
González-Del Vecchio M; Ruíz-Serrano MJ; Gijón P; Sánchez-Somolinos M; de Egea V; García de Viedma D; Sánchez Fresneda MN; Bouza E
Diagn Microbiol Infect Dis; 2016 Jul; 85(3):338-343. PubMed ID: 27157988
[TBL] [Abstract][Full Text] [Related]
58. [Aortic Complications Related to Mycobacterium bovis after Intravesical Bacille Calmette-Guérin Therapy - a Systematic Review].
Buerger M; Kapahnke S; Omran S; Müller V; Hinterseher I; Greiner A; Frese JP
Zentralbl Chir; 2021 Oct; 146(5):506-520. PubMed ID: 34666364
[TBL] [Abstract][Full Text] [Related]
59. BCG Aortitis, a Rare Complication of BCG Therapy.
Haddad J; Chalret du Rieu H; Ducasse E; Berard X; Caradu C
EJVES Vasc Forum; 2023; 58():23-27. PubMed ID: 36949865
[TBL] [Abstract][Full Text] [Related]
60. A Rare Case of Granulomatous Pneumonitis Due to Intravesical BCG for Bladder Cancer.
Clérigo V; Castro A; Mourato T; Gomes C
Acta Med Port; 2019 Apr; 32(4):316-320. PubMed ID: 31067427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
